CD66b+ neutrophil-like monocytes, as identified in the study by Horzum et al. in TMEs of breast and colon cancers, are a newly identified type of myeloid cell that is not affected by cancer-induced immune-suppressing effects and possesses strong proinflammatory abilities. This evidence concerns the gene CEACAM8 and malignant colon neoplasm.